Omicron-Specific Boosters No Better Than Initial Shots: Study

  • A small-scale independent study found that COVID-19 booster shots from Moderna and Pfizer-BioNTech do not increase neutralizing antibodies better than the original COVID-19 shots.
  • Columbia University and University of Michigan researchers found that the omicron booster did not induce more antibodies among 21 people who had received three shots with the original formula and a fourth shot of Moderna’s or Pfizer-BioNTech’s Omicron booster compared to 19 people who had received four shots targeting the original strain.
  • The study suggests the Omicron booster might not prevent people from becoming infected with the subvariant BA.5, which currently accounts for most COVID cases.

Continue to Article

Popular Now on Off The Press